Table 1.
Measures | SD | SDR | CD1 | CD2 | CDR | ID | IDR | ED | EDR |
---|---|---|---|---|---|---|---|---|---|
Trials to criterion | 8.35 | 9.37 | 10.87 | 8.73 | 9.63 | 9.67 | 10.49 | 21.26 | 8.22 |
(7.09) | (6.97) | (11.38) | (7.18) | (4.36) | (8.76) | (9.20) | (15.28) | (2.39) | |
Pass-Nr | 48 | 48 | 47 | 44 | 43 | 43 | 43 | 42 | 36 |
Wilcoxon-Z (comparing with last stage) | – | 3.04∗∗ | 0.42 | 0.10 | 3.05∗∗ | 1.84+ | 1.52 | 4.36∗∗∗ | 4.41∗∗∗ |
Trials to criterion: number of trials/choices required to complete a stage (values represent the mean values, standard deviations are shown in parentheses); Pass-Nr, number of participants successfully completing a stage; SD, Simple Discrimination; SDR, Simple Discrimination Reversal; CD1, Compound Discrimination 1; CD2, Compound Discrimination 2; CDR, Compound Discrimination Reversal; ID, Intradimensional Set Shifting; IDR, Intradimensional Set Shifting Reversal; ED, Extradimensional Set Shifting; EDR, Extradimensional Set Shifting Reversal; ∗∗p < 0.01; ∗∗∗p < 0.001, +p < 0.10.